世界のCD38モノクローナル抗体市場規模・現状・予測2021-2027

【英語タイトル】Global CD38 Monoclonal Antibodies Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR1166)・商品コード:QY21APR1166
・発行会社(調査会社):QYResearch
・発行日:2021年4月
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、CD38モノクローナル抗体の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ダラツムマブ、イサツキシマブ)、用途別市場規模(薬局、実験室用)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・CD38モノクローナル抗体の市場動向
・企業の競争状況、市場シェア
・CD38モノクローナル抗体の種類別市場規模(ダラツムマブ、イサツキシマブ)
・CD38モノクローナル抗体の用途別市場規模(薬局、実験室用)
・CD38モノクローナル抗体の北米市場規模2016-2027(アメリカ、カナダ)
・CD38モノクローナル抗体の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・CD38モノクローナル抗体のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・CD38モノクローナル抗体の中南米市場規模2016-2027(メキシコ、ブラジル)
・CD38モノクローナル抗体の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Johnson & Johnson、Sanofi、Janssen Biotech、Carbosynth、Creative Biolabs、BOC Sciences)
・結論
【レポートの概要】

CD38 monoclonal antibodies target the CD38 surface antigen(sAg) of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tumour growth by interrupting CD38 functions and causes cell death. CD38 monoclonal antibodies are used to treat multiple myeloma.

Market Analysis and Insights: Global CD38 Monoclonal Antibodies Market
The global CD38 Monoclonal Antibodies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CD38 Monoclonal Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CD38 Monoclonal Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CD38 Monoclonal Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CD38 Monoclonal Antibodies market.

Global CD38 Monoclonal Antibodies Scope and Market Size
CD38 Monoclonal Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CD38 Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Daratumumab
Isatuximab

Segment by Application
Pharmacy
Laboratory Use

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Sanofi
Janssen Biotech
Carbosynth

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD38 Monoclonal Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Daratumumab
1.2.3 Isatuximab
1.3 Market by Application
1.3.1 Global CD38 Monoclonal Antibodies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmacy
1.3.3 Laboratory Use
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CD38 Monoclonal Antibodies Market Perspective (2016-2027)
2.2 CD38 Monoclonal Antibodies Growth Trends by Regions
2.2.1 CD38 Monoclonal Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CD38 Monoclonal Antibodies Historic Market Share by Regions (2016-2021)
2.2.3 CD38 Monoclonal Antibodies Forecasted Market Size by Regions (2022-2027)
2.3 CD38 Monoclonal Antibodies Industry Dynamic
2.3.1 CD38 Monoclonal Antibodies Market Trends
2.3.2 CD38 Monoclonal Antibodies Market Drivers
2.3.3 CD38 Monoclonal Antibodies Market Challenges
2.3.4 CD38 Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CD38 Monoclonal Antibodies Players by Revenue
3.1.1 Global Top CD38 Monoclonal Antibodies Players by Revenue (2016-2021)
3.1.2 Global CD38 Monoclonal Antibodies Revenue Market Share by Players (2016-2021)
3.2 Global CD38 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CD38 Monoclonal Antibodies Revenue
3.4 Global CD38 Monoclonal Antibodies Market Concentration Ratio
3.4.1 Global CD38 Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD38 Monoclonal Antibodies Revenue in 2020
3.5 CD38 Monoclonal Antibodies Key Players Head office and Area Served
3.6 Key Players CD38 Monoclonal Antibodies Product Solution and Service
3.7 Date of Enter into CD38 Monoclonal Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CD38 Monoclonal Antibodies Breakdown Data by Type
4.1 Global CD38 Monoclonal Antibodies Historic Market Size by Type (2016-2021)
4.2 Global CD38 Monoclonal Antibodies Forecasted Market Size by Type (2022-2027)

5 CD38 Monoclonal Antibodies Breakdown Data by Application
5.1 Global CD38 Monoclonal Antibodies Historic Market Size by Application (2016-2021)
5.2 Global CD38 Monoclonal Antibodies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CD38 Monoclonal Antibodies Market Size (2016-2027)
6.2 North America CD38 Monoclonal Antibodies Market Size by Type
6.2.1 North America CD38 Monoclonal Antibodies Market Size by Type (2016-2021)
6.2.2 North America CD38 Monoclonal Antibodies Market Size by Type (2022-2027)
6.2.3 North America CD38 Monoclonal Antibodies Market Size by Type (2016-2027)
6.3 North America CD38 Monoclonal Antibodies Market Size by Application
6.3.1 North America CD38 Monoclonal Antibodies Market Size by Application (2016-2021)
6.3.2 North America CD38 Monoclonal Antibodies Market Size by Application (2022-2027)
6.3.3 North America CD38 Monoclonal Antibodies Market Size by Application (2016-2027)
6.4 North America CD38 Monoclonal Antibodies Market Size by Country
6.4.1 North America CD38 Monoclonal Antibodies Market Size by Country (2016-2021)
6.4.2 North America CD38 Monoclonal Antibodies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe CD38 Monoclonal Antibodies Market Size (2016-2027)
7.2 Europe CD38 Monoclonal Antibodies Market Size by Type
7.2.1 Europe CD38 Monoclonal Antibodies Market Size by Type (2016-2021)
7.2.2 Europe CD38 Monoclonal Antibodies Market Size by Type (2022-2027)
7.2.3 Europe CD38 Monoclonal Antibodies Market Size by Type (2016-2027)
7.3 Europe CD38 Monoclonal Antibodies Market Size by Application
7.3.1 Europe CD38 Monoclonal Antibodies Market Size by Application (2016-2021)
7.3.2 Europe CD38 Monoclonal Antibodies Market Size by Application (2022-2027)
7.3.3 Europe CD38 Monoclonal Antibodies Market Size by Application (2016-2027)
7.4 Europe CD38 Monoclonal Antibodies Market Size by Country
7.4.1 Europe CD38 Monoclonal Antibodies Market Size by Country (2016-2021)
7.4.2 Europe CD38 Monoclonal Antibodies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CD38 Monoclonal Antibodies Market Size (2016-2027)
8.2 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Type
8.2.1 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Type (2016-2027)
8.3 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Application
8.3.1 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Application (2016-2027)
8.4 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Region
8.4.1 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CD38 Monoclonal Antibodies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CD38 Monoclonal Antibodies Market Size (2016-2027)
9.2 Latin America CD38 Monoclonal Antibodies Market Size by Type
9.2.1 Latin America CD38 Monoclonal Antibodies Market Size by Type (2016-2021)
9.2.2 Latin America CD38 Monoclonal Antibodies Market Size by Type (2022-2027)
9.2.3 Latin America CD38 Monoclonal Antibodies Market Size by Type (2016-2027)
9.3 Latin America CD38 Monoclonal Antibodies Market Size by Application
9.3.1 Latin America CD38 Monoclonal Antibodies Market Size by Application (2016-2021)
9.3.2 Latin America CD38 Monoclonal Antibodies Market Size by Application (2022-2027)
9.3.3 Latin America CD38 Monoclonal Antibodies Market Size by Application (2016-2027)
9.4 Latin America CD38 Monoclonal Antibodies Market Size by Country
9.4.1 Latin America CD38 Monoclonal Antibodies Market Size by Country (2016-2021)
9.4.2 Latin America CD38 Monoclonal Antibodies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CD38 Monoclonal Antibodies Market Size (2016-2027)
10.2 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Type
10.2.1 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Type (2016-2027)
10.3 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Application
10.3.1 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Application (2016-2027)
10.4 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Country
10.4.1 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CD38 Monoclonal Antibodies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson CD38 Monoclonal Antibodies Introduction
11.1.4 Johnson & Johnson Revenue in CD38 Monoclonal Antibodies Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi CD38 Monoclonal Antibodies Introduction
11.2.4 Sanofi Revenue in CD38 Monoclonal Antibodies Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Janssen Biotech
11.3.1 Janssen Biotech Company Details
11.3.2 Janssen Biotech Business Overview
11.3.3 Janssen Biotech CD38 Monoclonal Antibodies Introduction
11.3.4 Janssen Biotech Revenue in CD38 Monoclonal Antibodies Business (2016-2021)
11.3.5 Janssen Biotech Recent Development
11.4 Carbosynth
11.4.1 Carbosynth Company Details
11.4.2 Carbosynth Business Overview
11.4.3 Carbosynth CD38 Monoclonal Antibodies Introduction
11.4.4 Carbosynth Revenue in CD38 Monoclonal Antibodies Business (2016-2021)
11.4.5 Carbosynth Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs CD38 Monoclonal Antibodies Introduction
11.5.4 Creative Biolabs Revenue in CD38 Monoclonal Antibodies Business (2016-2021)
11.5.5 Creative Biolabs Recent Development
11.6 BOC Sciences
11.6.1 BOC Sciences Company Details
11.6.2 BOC Sciences Business Overview
11.6.3 BOC Sciences CD38 Monoclonal Antibodies Introduction
11.6.4 BOC Sciences Revenue in CD38 Monoclonal Antibodies Business (2016-2021)
11.6.5 BOC Sciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CD38 Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Daratumumab
Table 3. Key Players of Isatuximab
Table 4. Global CD38 Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global CD38 Monoclonal Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global CD38 Monoclonal Antibodies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global CD38 Monoclonal Antibodies Market Share by Regions (2016-2021)
Table 8. Global CD38 Monoclonal Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global CD38 Monoclonal Antibodies Market Share by Regions (2022-2027)
Table 10. CD38 Monoclonal Antibodies Market Trends
Table 11. CD38 Monoclonal Antibodies Market Drivers
Table 12. CD38 Monoclonal Antibodies Market Challenges
Table 13. CD38 Monoclonal Antibodies Market Restraints
Table 14. Global CD38 Monoclonal Antibodies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global CD38 Monoclonal Antibodies Market Share by Players (2016-2021)
Table 16. Global Top CD38 Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD38 Monoclonal Antibodies as of 2020)
Table 17. Ranking of Global Top CD38 Monoclonal Antibodies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by CD38 Monoclonal Antibodies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CD38 Monoclonal Antibodies Product Solution and Service
Table 21. Date of Enter into CD38 Monoclonal Antibodies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD38 Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Table 25. Global CD38 Monoclonal Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global CD38 Monoclonal Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2016-2021)
Table 29. Global CD38 Monoclonal Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America CD38 Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America CD38 Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America CD38 Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America CD38 Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America CD38 Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America CD38 Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe CD38 Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe CD38 Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe CD38 Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe CD38 Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe CD38 Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe CD38 Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific CD38 Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific CD38 Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific CD38 Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific CD38 Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific CD38 Monoclonal Antibodies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific CD38 Monoclonal Antibodies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America CD38 Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America CD38 Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America CD38 Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America CD38 Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America CD38 Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America CD38 Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa CD38 Monoclonal Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa CD38 Monoclonal Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa CD38 Monoclonal Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa CD38 Monoclonal Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa CD38 Monoclonal Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa CD38 Monoclonal Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson CD38 Monoclonal Antibodies Product
Table 64. Johnson & Johnson Revenue in CD38 Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi CD38 Monoclonal Antibodies Product
Table 69. Sanofi Revenue in CD38 Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Janssen Biotech Company Details
Table 72. Janssen Biotech Business Overview
Table 73. Janssen Biotech CD38 Monoclonal Antibodies Product
Table 74. Janssen Biotech Revenue in CD38 Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 75. Janssen Biotech Recent Development
Table 76. Carbosynth Company Details
Table 77. Carbosynth Business Overview
Table 78. Carbosynth CD38 Monoclonal Antibodies Product
Table 79. Carbosynth Revenue in CD38 Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 80. Carbosynth Recent Development
Table 81. Creative Biolabs Company Details
Table 82. Creative Biolabs Business Overview
Table 83. Creative Biolabs CD38 Monoclonal Antibodies Product
Table 84. Creative Biolabs Revenue in CD38 Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 85. Creative Biolabs Recent Development
Table 86. BOC Sciences Company Details
Table 87. BOC Sciences Business Overview
Table 88. BOC Sciences CD38 Monoclonal Antibodies Product
Table 89. BOC Sciences Revenue in CD38 Monoclonal Antibodies Business (2016-2021) & (US$ Million)
Table 90. BOC Sciences Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD38 Monoclonal Antibodies Market Share by Type: 2020 VS 2027
Figure 2. Daratumumab Features
Figure 3. Isatuximab Features
Figure 4. Global CD38 Monoclonal Antibodies Market Share by Application: 2020 VS 2027
Figure 5. Pharmacy Case Studies
Figure 6. Laboratory Use Case Studies
Figure 7. CD38 Monoclonal Antibodies Report Years Considered
Figure 8. Global CD38 Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global CD38 Monoclonal Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global CD38 Monoclonal Antibodies Market Share by Regions: 2020 VS 2027
Figure 11. Global CD38 Monoclonal Antibodies Market Share by Regions (2022-2027)
Figure 12. Global CD38 Monoclonal Antibodies Market Share by Players in 2020
Figure 13. Global Top CD38 Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD38 Monoclonal Antibodies as of 2020
Figure 14. The Top 10 and 5 Players Market Share by CD38 Monoclonal Antibodies Revenue in 2020
Figure 15. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Figure 16. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2022-2027)
Figure 17. North America CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America CD38 Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 19. North America CD38 Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 20. North America CD38 Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 21. United States CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe CD38 Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 25. Europe CD38 Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 26. Europe CD38 Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 27. Germany CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific CD38 Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 35. Asia-Pacific CD38 Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 36. Asia-Pacific CD38 Monoclonal Antibodies Market Share by Region (2016-2027)
Figure 37. China CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America CD38 Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 45. Latin America CD38 Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 46. Latin America CD38 Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 47. Mexico CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa CD38 Monoclonal Antibodies Market Share by Type (2016-2027)
Figure 51. Middle East & Africa CD38 Monoclonal Antibodies Market Share by Application (2016-2027)
Figure 52. Middle East & Africa CD38 Monoclonal Antibodies Market Share by Country (2016-2027)
Figure 53. Turkey CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE CD38 Monoclonal Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Johnson & Johnson Revenue Growth Rate in CD38 Monoclonal Antibodies Business (2016-2021)
Figure 57. Sanofi Revenue Growth Rate in CD38 Monoclonal Antibodies Business (2016-2021)
Figure 58. Janssen Biotech Revenue Growth Rate in CD38 Monoclonal Antibodies Business (2016-2021)
Figure 59. Carbosynth Revenue Growth Rate in CD38 Monoclonal Antibodies Business (2016-2021)
Figure 60. Creative Biolabs Revenue Growth Rate in CD38 Monoclonal Antibodies Business (2016-2021)
Figure 61. BOC Sciences Revenue Growth Rate in CD38 Monoclonal Antibodies Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed


【掲載企業】

Johnson & Johnson、Sanofi、Janssen Biotech、Carbosynth、Creative Biolabs、BOC Sciences

★調査レポート[世界のCD38モノクローナル抗体市場規模・現状・予測2021-2027] (コード:QY21APR1166)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のCD38モノクローナル抗体市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆